Certified by Founder
Lodge
AvenCell
start up
United States
- Cambridge, Massachusetts
- 22/10/2024
- Series B
- $112,000,000
Based on our deep science and focused on patients in need, we develop next generation immunotherapies for hard-to-treat cancers.
- Industry Biotechnology
- Website https://avencell.com/
- LinkedIn https://www.linkedin.com/company/avencell/
Gangkhar | $4,250,000 | (Mar 17, 2026)
Malama Health | $9,200,000 | (Mar 17, 2026)
Arycs Technologies | $24,000,000 | (Mar 13, 2026)
Mantis Space | $10,000,000 | (Mar 13, 2026)
Ezra(2) | $8,000,000 | (Mar 13, 2026)
Freestyle | $10,000,000 | (Mar 13, 2026)
Monteris Medical | $28,000,000 | (Mar 13, 2026)
Gumloop | $50,000,000 | (Mar 13, 2026)
Combat Medical Ltd | $3,472,639 | (Mar 13, 2026)
Qurrent | $15,000,000 | (Mar 13, 2026)
Waiv, formerly Owkin Dx | $33,000,000 | (Mar 13, 2026)
Carefam | $14,500,000 | (Mar 13, 2026)